Invention Grant
- Patent Title: Targeting microRNA-26a/b for the treatment of neurodegenerative disease
-
Application No.: US14917065Application Date: 2014-09-10
-
Publication No.: US09951331B2Publication Date: 2018-04-24
- Inventor: Anna M. Krichevsky
- Applicant: The Brigham and Women's Hospital, Inc.
- Applicant Address: US MA Boston
- Assignee: The Brigham and Women's Hospital, Inc.
- Current Assignee: The Brigham and Women's Hospital, Inc.
- Current Assignee Address: US MA Boston
- Agency: Fish & Richardson P.C.
- International Application: PCT/US2014/054923 WO 20140910
- International Announcement: WO2015/038593 WO 20150319
- Main IPC: C12N15/113
- IPC: C12N15/113 ; A61K31/7105 ; A61K31/712 ; A61K31/7125 ; A61K45/06
Abstract:
Methods for treating a neurodegenerative disorder associated with aggregation of tau protein in the brain of a subject, comprising administering to the subject a therapeutically effective amount of one or more inhibitory nucleic acids targeting microRNA-26a, microRNA-26b, or both microRNA-26a and 26b.
Public/Granted literature
- US20160272968A1 Targeting microRNA-26a/b for the Treatment of Neurodegenerative Disease Public/Granted day:2016-09-22
Information query
IPC分类:
